Pill Identifier App

LAMISIL 250 (Lamisil 250 mg)

Generic Name: terbinafine

Pill imprint LAMISIL 250 has been identified as Lamisil 250 mg.

Lamisil is used in the treatment of onychomycosis, toenail; tinea corporis; cutaneous candidiasis; tinea capitis; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for LAMISIL 250

Lamisil 250 mg LAMISIL 250 Front
Lamisil 250 mg LAMISIL 250 Back
Lamisil 250 mg LAMISIL 250
Lamisil 250 mg LAMISIL 250
Lamisil
Generic Name:
terbinafine
Imprint:
LAMISIL
250
Strength:
250 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0179
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55289-0513 PDRX Pharmaceuticals Inc (repackager)
54868-4008 Physicians Total Care Inc (repackager)
49999-0466 Lake Erie Medical and Surgical Supply (repackager)
23490-6961 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)